Showing results (161-170 of 263) with videos related to
Sort By:
Pageof 27
The Journal of Clinical Endocrinology and Metabolism|December 1, 1996
Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onsetD O Hardy, H I Scher, T Bogenreider, et al.Seminars in Oncology|December 1, 1996
Targeted therapy for prostate cancer: the Memorial Sloan-Kettering Cancer Center approachS F Slovin, P O Livingston, N Rosen, et al.Cancer Treatment Reports|October 1, 1987
Gallium nitrate in prostatic cancer: evaluation of antitumor activity and effects on bone turnoverH I Scher, T Curley, N Geller, et al.Cancer Chemotherapy and Pharmacology|January 1, 1986
Etoposide in prostatic cancer: experimental studies and phase II trial in patients with bidimensionally measurable diseaseH I Scher, C Sternberg, W D Heston, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancerI Osman, H I Scher, M Drobnjak, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 31, 1992
Extra-uterine endometrial stromal sarcoma with DNA flow cytometric analysisM E Vierhout, S Chadha-Ajwani, J A Wijnen, et al.Cancer Chemotherapy and Pharmacology|January 1, 1991
Phase II study of ACNU in non-small-cell lung cancer: EORTC study 08872A S Planting, A Ardizzoni, J Estapé, et al.Prostate Cancer and Prostatic Diseases|December 24, 2002
The microtubule-stabilizing agents epothilones A and B and their desoxy-derivatives induce mitotic arrest and apoptosis in human prostate cancer cellsL Sepp-Lorenzino, A Balog, D-S Su, et al.British Journal of Cancer|November 1, 1996
Survival of patients with advanced urothelial cancer treated with cisplatin-based chemotherapyS D Fosså, C Sternberg, H I Scher, et al.Cancer|December 1, 1993
Suramin for germ cell tumors. In vitro growth inhibition and results of a phase II trialR J Motzer, E Dmitrovsky, W H Miller, et al.Pageof 27